Response to Paik et al. on the disease burden of NAFLD
- PMID: 37437540
- DOI: 10.1016/j.cmet.2023.05.012
Response to Paik et al. on the disease burden of NAFLD
Abstract
Chew and Ng et al. recently reported on the global burden of metabolic disease by utilizing estimates from the Global Burden of Disease (GBD) study. Herein, they respond to critical points highlighted by Paik et al. regarding the limitations of the GBD database as well as the definitions employed in the study.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests D.Q.H. has served as an advisory board member for Eisai and receives funding support from the Singapore Ministry of Health’s National Medical Research Council under its NMRC Research Training Fellowship (MOH-000595-01). C.H.N. has served as a consultant for Boxer Capital.
Comment on
-
The global burden of metabolic disease: Data from 2000 to 2019.Cell Metab. 2023 Mar 7;35(3):414-428.e3. doi: 10.1016/j.cmet.2023.02.003. Cell Metab. 2023. PMID: 36889281
-
Nonalcoholic fatty liver disease mortality may not be decreasing: A need for careful interpretation of GBD 2019 estimates of liver deaths.Cell Metab. 2023 Jul 11;35(7):1087-1088. doi: 10.1016/j.cmet.2023.06.012. Cell Metab. 2023. PMID: 37437539
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
